APICES Trademark

Trademark Overview

On Wednesday, June 9, 2010, a trademark application was filed for APICES with the United States Patent and Trademark Office. The USPTO has given the APICES trademark a serial number of 85058091. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 9, 2013. This trademark is owned by Celgene Corporation. The APICES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast; conducting clinical trials on the safety and effectiveness of a drug for Psoriasis, Rheumatoid Arthritis and Cancer; conducting clinical trials on the safety and effectiveness of a drug directed to Prostate-specific antigen
apices

General Information

Serial Number85058091
Word MarkAPICES
Filing DateWednesday, June 9, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 9, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 7, 2010

Trademark Statements

Goods and ServicesConducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast; conducting clinical trials on the safety and effectiveness of a drug for Psoriasis, Rheumatoid Arthritis and Cancer; conducting clinical trials on the safety and effectiveness of a drug directed to Prostate-specific antigen

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 14, 2010
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Monday, December 9, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 9, 2013ABANDONMENT - NO USE STATEMENT FILED
Friday, March 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2013EXTENSION 5 GRANTED
Friday, March 22, 2013EXTENSION 5 FILED
Friday, March 22, 2013TEAS EXTENSION RECEIVED
Friday, October 19, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 18, 2012EXTENSION 4 GRANTED
Tuesday, October 16, 2012EXTENSION 4 FILED
Tuesday, October 16, 2012TEAS EXTENSION RECEIVED
Wednesday, April 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 17, 2012EXTENSION 3 GRANTED
Thursday, April 12, 2012EXTENSION 3 FILED
Thursday, April 12, 2012TEAS EXTENSION RECEIVED
Saturday, September 10, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 9, 2011EXTENSION 2 GRANTED
Wednesday, September 7, 2011EXTENSION 2 FILED
Friday, September 9, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 7, 2011TEAS EXTENSION RECEIVED
Thursday, March 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 15, 2011EXTENSION 1 GRANTED
Tuesday, March 15, 2011EXTENSION 1 FILED
Tuesday, March 15, 2011TEAS EXTENSION RECEIVED
Tuesday, November 2, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 7, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2010PUBLISHED FOR OPPOSITION
Monday, August 2, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 2, 2010ASSIGNED TO LIE
Monday, July 19, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 12, 2010ASSIGNED TO EXAMINER
Monday, June 14, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 12, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

apices trials clinical conducting effectiveness safety drug prostate specific antigen directed